Bluefin Capital Management’s AbbVie ABBV Stock Holding History

Bluefin Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-100,000	Closed	-$1.55M	–	387
2020 Q1	$1.55M	Buy	+100,000	New	+$8.52M	0.2%	88
2019 Q4	–	Sell	-109,700	Closed	-$97K	–	602
2019 Q3	$97K	Buy	+109,700	New	+$7.52M	0.01%	318
2019 Q2	–	Sell	-14,000	Closed	-$26K	–	331
2019 Q1	$26K	Buy	+14,000	New	+$1.15M	﹤0.01%	317
2018 Q4	–	Sell	-30,400	Closed	-$49K	–	410
2018 Q3	$49K	Buy	+30,400	New	+$2.88M	﹤0.01%	399

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bluefin Capital Management's ABBV Position: Q4 2023 in Review

Bluefin Capital Management sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 1,500 shares — an estimated $224K sold.

Bluefin Capital Management first reported a position in ABBV in Q2 2013 and held it in 28 quarters. The position peaked at $13.5M in Q1 2020. 3,323 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

Bluefin Capital Management reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
Bluefin Capital Management sold 1,500 AbbVie shares in Q4 2023, an estimated $224K.
Bluefin Capital Management first reported a position in AbbVie in Q2 2013 and held it in 28 quarters.
Bluefin Capital Management's AbbVie position peaked at $13.5M in Q1 2020.
3,323 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Bluefin Capital Management's 13F filing for Q4 2023, filed 16 Feb 2024.